eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Licensing for formulation of a malaria antigen for use as a human malaria vaccine

eagle-i ID

http://hawaii.eagle-i.net/i/00000130-2884-67df-cec9-714480000000

Resource Type

  1. Access service

Properties

  1. Resource Description
    "This technology deals with compositions of the baculovirus MSP1 p42 polypeptide and adjuvants which comprise immunogenic formulations in non-human primates. Studies have identified two pharmaceutically-acceptable adjuvants capable of inducing a potent humoral and cellular immune responses in Aotus and conferring partial protection against P. falciparum infection."
  2. Contact
    Taylor, Lee
  3. Service Provided by
    Office of Technology Transfer and Economic Development (OTTED)
  4. Website(s)
    http://www.otted.hawaii.edu/technology/00220/formulation-malaria-antigen-clinically-acceptably-adjuvants-use-human-malaria-vacci
 
RDFRDF
 
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016